Original Article

You have full text access to this OnlineOpen article

Adjuvant treatments do not alter the quality of life in elderly patients with colorectal cancer

A population-based study

  1. Anne-Marie Bouvier MD, PhD1,2,†,*,
  2. Valérie Jooste PhD1,2,
  3. Franck Bonnetain PhD3,
  4. Vanessa Cottet PhD1,2,
  5. Marie-Hélène Bizollon MD4,
  6. Marie-Pierre Bernard MD1,2,
  7. Jean Faivre MD, PhD1,2

Article first published online: 2 JUN 2008

DOI: 10.1002/cncr.23629

Issue

Cancer

Cancer

Volume 113, Issue 4, pages 879–886, 15 August 2008

Additional Information

How to Cite

Bouvier, A.-M., Jooste, V., Bonnetain, F., Cottet, V., Bizollon, M.-H., Bernard, M.-P. and Faivre, J. (2008), Adjuvant treatments do not alter the quality of life in elderly patients with colorectal cancer. Cancer, 113: 879–886. doi: 10.1002/cncr.23629

Author Information

  1. 1

    Burgundy Digestive Cancer Registry, Inserm U866 and CIC-EC, University of Bourgogne, Dijon, France

  2. 2

    University Hospital, Dijon, France

  3. 3

    French-Speaking Federation of Digestive Oncology, Dijon, France

  4. 4

    Pathology Anatomy and Cytology Laboratory, Chalon-sur-Saône, France

  1. †

    Fax: (011) 33 3 80 66 82 51

*Burgundy Digestive Cancer Registry (INSERM U866), School of Medicine, BP 87 900 21079 Dijon Cedex, France

Publication History

  1. Issue published online: 1 AUG 2008
  2. Article first published online: 2 JUN 2008
  3. Manuscript Accepted: 13 MAR 2008
  4. Manuscript Revised: 25 FEB 2008
  5. Manuscript Received: 8 JAN 2008

Funded by

  • The Hospital Clinical Research Program (PHRC)
  • Health French Ministry (2004)
  • Regional Council of Bourgogne (2004)

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article (HTML) Get PDF (232K)

REFERENCES

  • 1
    Bouvier AM,Remontet L,Jougla E, et al. Incidence of digestive cancers in France. Gastroenterol Clin Biol. 2004; 28: 877–881.
  • 2
    Anthony T,Jones C,Antoine J, et al. The effect of treatment for colorectal cancer on long-term health-related quality of life. Ann Surg Oncol. 2001; 8: 44–49.
  • 3
    Moertel CG,Fleming TR,Macdonald JS, et al. Levamisole and fluorouracil for adjuvant therapy of resected colon carcinoma. N Engl J Med. 1990; 322: 352–358.
  • 4
    Faivre-Finn C,Benhamiche AM,Maingon P, et al. Changes in the practice of adjuvant radiotherapy in resectable rectal cancer within a French well-defined population. Radiother Oncol. 2000; 57: 137–142.
  • 5
    Faivre-Finn C,Bouvier AM,Mitry E, et al. Chemotherapy for colon cancer in a well-defined French population: is it under- or over-prescribed? Aliment Pharmacol Ther. 2002; 16: 353–359.
    Direct Link:
  • 6
    Ayanian JZ,Zaslavsky AM,Fuchs CS, et al. Use of adjuvant chemotherapy and radiation therapy for colorectal cancer in a population-based cohort. J Clin Oncol. 2003; 21: 1293–1300.
  • 7
    Sundararajan V,Grann VR,Jacobson JS, et al. Variations in the use of adjuvant chemotherapy for node-positive colon cancer in the elderly: a population-based study. Cancer J. 2001; 7: 213–218.
  • 8
    Bouvier AM,Launoy G,Lepage C, et al. Trends in the management and survival of digestive tract cancers among patients aged over 80 years. Aliment Pharmacol Ther. 2005; 22: 233–241.
    Direct Link:
  • 9
    Fayers S,Aaronson N,Bjordal K, et al. EORTC QLQ-C30 Scoring Manual. 3rd ed. Brussels, Belgium: EORTC Study Group on Quality of Life; 2001.
  • 10
    Anderson RT,Aaronson NK,Wilkin D. Critical review of the international assessments of health-related quality of life. Qual Life Res. 1993; 2: 369–395.
  • 11
    Spitzer WO,Dobson AJ,Hall J, et al. Measuring the quality of life of cancer patients: a concise QL-index for use by physicians. J Chronic Dis. 1981; 34: 585–597.
  • 12
    World Health Organization. International Classification of Diseases for Oncology. Geneva: World Health Organization; 1992.
  • 13
    Rubin P,Hansen J. TNM staging atlas. Geneva: World Health Organization; 2007.
  • 14
    Laurie JA,Moertel CG,Fleming TR, et al. Surgical adjuvant therapy of large-bowel carcinoma: an evaluation of levamisole and the combination of levamisole and fluorouracil. The North Central Cancer Treatment Group and the Mayo Clinic. J Clin Oncol. 1989; 7: 1447–1456.
  • 15
    Conference de Consensus. Prevention, depistage et prise en charge des cancers du colon. Gastroenterol Clin Biol. 1998; 22: S275–S288.
  • 16
    Neugut AI,Fleischauer AT,Sundararajan V, et al. Use of adjuvant chemotherapy and radiation therapy for rectal cancer among the elderly: a population-based study. J Clin Oncol. 2002; 20: 2643–2650.
  • 17
    Pahlman L,Glimelius B. Pre- or postoperative radiotherapy in rectal and rectosigmoid carcinoma. Report from a randomized multicenter trial. Ann Surg. 1990; 211: 187–195.
  • 18
    Sauer R,Becker H,Hohenberger W, et al. Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med. 2004; 351: 1731–1740.
  • 19
    Osoba D,Rodrigues G,Myles J, et al. Interpreting the significance of changes in health-related quality-of-life scores. J Clin Oncol. 1998; 16: 139–144.
  • 20
    Cnaan A,Laird NM,Slasor P. Using the general linear mixed model to analyse unbalanced repeated measures and longitudinal data. Stat Med. 1997; 16: 2349–2380.
    Direct Link:
  • 21
    Pauler DK,McCoy S,Moinpour C. Pattern mixture models for longitudinal quality of life studies in advanced stage disease. Stat Med. 2003; 22: 795–809.
    Direct Link:
  • 22
    Fairclough DL,Gagnon DD,Zagari MJ, et al. Evaluation of quality of life in a clinical trial with nonrandom dropout: the effect of epoetin alfa in anemic cancer patients. Qual Life Res. 2003; 12: 1013–1027.
  • 23
    Fairclough DL,Peterson HF,Cella D, et al. Comparison of several model-based methods for analysing incomplete quality of life data in cancer clinical trials. Stat Med. 1998; 17: 781–796.
    Direct Link:
  • 24
    Seymour M,Tabah-Fish I,Homerin M. Quality of Life (QoL) in advanced colorectal cancer (ACC): a comparison of QoL during bolus plus infusion 5FU/Leucovorin (LV5FU2) with or without oxaliplatin [abstract]. Proc Am Soc Clin Oncol. 1999; 18: 234a.
  • 25
    Osoba D. Lessons learned from measuring health-related quality of life in oncology. J Clin Oncol. 1994; 12: 608–616.
  • 26
    Bouchardy C,Queneau PE,Fioretta G, et al. Adjuvant chemotherapy for colon carcinoma with positive lymph nodes: use and benefit in routine health care practice. Br J Cancer. 2001; 85: 1251–1257.
  • 27
    Lemmens VE,van Halteren AH,Janssen-Heijnen ML, et al. Adjuvant treatment for elderly patients with stage III colon cancer in the southern Netherlands is affected by socioeconomic status, gender, and comorbidity. Ann Oncol. 2005; 16: 767–772.
  • 28
    Newcomb PA,Carbone PP. Cancer treatment and age: patient perspectives. J Natl Cancer Inst. 1993; 85: 1580–1584.
  • 29
    Padilla GV,Grant MM,Lipsett J, et al. Health quality of life and colorectal cancer. Cancer. 1992; 70( 5 suppl): 1450–1456.
    Direct Link:
  • 30
    Ulander K,Jeppsson B,Grahn G. Quality of life and independence in activities of daily living preoperatively and at follow-up in patients with colorectal cancer. Support Care Cancer. 1997; 5: 402–409.
View Full Article (HTML) Get PDF (232K)